Uncategorized

La Jolla Institute for Immunology and RevolKa started a Research Collaboration

RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.

La Jolla Institute for Immunology and RevolKa started a Research Collaboration Read More »

Scroll to Top